Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy.

J Gynecol Oncol · 2022 · PMC9634092 · PMID 36047374

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

marginally significantp=0.098so close (0.05 < p ≤ 0.1)

HPVI ADC (77.3%) showed a lower LRFS than HPVA ADC (91.8%), and the difference was marginally significant (p=0.098).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.